Amgen To Open Manufacturing Site In Central Ohio; To Offer 400 Full-time Jobs

Amgen's Bkemv Approved As First Interchangeable Biosimilar To Soliris

The U.S. Food and Drug Administration has approved Amgen Inc.'s Bkemv (eculizumab-aeeb) as the first interchangeable biosimilar to Soliris (eculizumab), developed by British drug major AstraZeneca's Rare Disease unit Alexion Pharmaceuticals, to treat certain rare diseases. Soliris is a medicine used to treat adults and children with paroxysmal nocturnal haemoglobinuria or PNH...

RTTNews | 365日前

Amgen Says FDA Completes Review Of SNDA Seeking Full Approval For LUMAKRAS

Amgen, Inc. (AMGN) announced Tuesday that the U.S. Food and Drug Administration (FDA) has completed its review of the company's supplemental New Drug Application seeking full approval of LUMAKRAS (sotorasib).

RTTNews | 521日前

Amgen, Horizon Therapeutics Reach Settlement On FTC Lawsuit; Seeks To Close Acquisition In Q4

Amgen (AMGN) and Horizon Therapeutics plc (HZNP) announced Friday the entry into a consent order agreement with the Federal Trade Commission (FTC) that resolves the pending FTC administrative lawsuit. This clears the path to take the final steps to close Amgen's $27.8 billion acquisition of Horizon.

RTTNews | 637日前

Amgen Announces Positive Top-line Results From Phase 3 DAHLIA Study Of ABP 959

Amgen, Inc. (AMGN) announced Tuesday positive top-line results from the DAHLIA study, a randomized, double-blind, active-controlled, two-period crossover Phase 3 study evaluating the efficacy and safety of ABP 959, a biosimilar candidate to SOLIRIS (eculizumab), compared with SOLIRIS in adult patients with paroxysmal nocturnal hemoglobinuria (PNH).

RTTNews | 1011日前

Swiss Market Ends Modestly Higher

Save for a few minutes at the start when it stayed a bit weak, the Switzerland market remained positive on Friday, and despite coming off the day's high hit around noon, ended the session modestly higher.

RTTNews | 2時9分前

Major European Markets Close Slightly Higher

Despite uncertainty surrounding Trump administration's tariff plans, The major European markets mostly closed higher on Friday. Trade tensions escalated after the U.S. President accused China of violating trade agreement reached earlier this month, but investors picked up stocks amid expectations of an interest rate cut by the European Central Bank.

RTTNews | 2時34分前

Canadian Market Modestly Lower, Looks Headed For Another Weak Close

The Canadian market is exhibiting weakness on Friday, weighed down by losses in energy, healthcare and technology sectors. Amid renewed concerns about a global trade war, the mood in the market remains cautious.

RTTNews | 3時31分前

U.S. Stocks Broadly Lower In Cautious Trade

U.S. stocks are turning in a weak performance on Friday amid renewed concerns over trade tensions, and a batch of mixed economic data. The major averages all are down in negative territory, with the tech-laden Nasdaq underperforming.

RTTNews | 4時3分前

EURUSD	1.13599	GBPUSD	1.34709	AUDUSD	0.64439
USDJPY	143.889	USDCAD	1.37178	USDCHF	0.8223

Advertisement

Amgen To Open Manufacturing Site In Central Ohio; To Offer 400 Full-time Jobs